Genome-Edited T Cell Therapies
- PMID: 35773047
- DOI: 10.1016/j.hoc.2022.03.006
Genome-Edited T Cell Therapies
Abstract
Chimeric antigen receptor (CAR) T-cells are widely being investigated against malignancies, and allogeneic 'universal donor' CAR-T cells offer the possibility of widened access to pre-manufactured, off-the-shelf therapies. Different genome-editing platforms have been used to address human leukocyte antigen (HLA) barriers to generate universal CAR-T cell therapy and early applications have been reported in children and adults against B cell malignancies. Recently developed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based systems and related technologies offer the prospect of enhanced cellular immunotherapies for a wider range of hematological malignancies.
Keywords: Base editor; CRISPR/Cas9; Chimeric antigen receptor; Cytidine deamination; Genome editing; T cell therapies.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.Hum Immunol. 2018 Dec;79(12):876-882. doi: 10.1016/j.humimm.2018.09.007. Epub 2018 Sep 24. Hum Immunol. 2018. PMID: 30261221 Review.
-
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cells.Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2427216122. doi: 10.1073/pnas.2427216122. Epub 2025 May 5. Proc Natl Acad Sci U S A. 2025. PMID: 40324075
-
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy.J Exp Clin Cancer Res. 2021 Aug 26;40(1):269. doi: 10.1186/s13046-021-02076-5. J Exp Clin Cancer Res. 2021. PMID: 34446084 Free PMC article. Review.
-
Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy.Brief Funct Genomics. 2020 May 20;19(3):175-182. doi: 10.1093/bfgp/elz042. Brief Funct Genomics. 2020. PMID: 31950135 Free PMC article. Review.
-
Clinical development of allogeneic chimeric antigen receptor αβ-T cells.Mol Ther. 2025 Jun 4;33(6):2426-2440. doi: 10.1016/j.ymthe.2025.03.040. Epub 2025 Mar 27. Mol Ther. 2025. PMID: 40156192 Review.
Cited by
-
Gene Therapy for Inherited Liver Disease: To Add or to Edit.Int J Mol Sci. 2024 Nov 21;25(23):12514. doi: 10.3390/ijms252312514. Int J Mol Sci. 2024. PMID: 39684224 Free PMC article. Review.
-
A comprehensive analysis of the major specificities of anti-human T lymphocyte porcine immunoglobulin (p-ATG).Ann Hematol. 2025 Jan;104(1):761-771. doi: 10.1007/s00277-024-06028-9. Epub 2024 Oct 15. Ann Hematol. 2025. PMID: 39402313 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials